Gene · 3161
Papers2,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Synthetic hyaluronic acid coating preserves the phenotypes of lymphatic endothelial cells. | Biomater Sci | 2023 | 37789798 | PubTator, text mining | PubMed |
| Tumorigenic effects of human mesenchymal stromal cells and fibroblasts on bladder cancer cells. | Front Oncol | 2023 | 37781195 | PubTator, text mining | PubMed |
| Computational Study of Complex Formation between Hyaluronan Polymers and Polyarginine Peptides at Various Ratios. | Langmuir | 2023 | 37773978 | PubTator, text mining | PubMed |
| Identification of differential immune cells and related diagnostic genes in patients with diabetic retinopathy. | Medicine (Baltimore) | 2023 | 37773794 | PubTator, text mining | PubMed |
| Hyaluronic Acid in Rheumatology. | Pharmaceutics | 2023 | 37765216 | PubTator, text mining | PubMed |
| Polysaccharide-Based Coatings as Drug Delivery Systems. | Pharmaceutics | 2023 | 37765196 | PubTator, text mining | PubMed |
| Hyperbranched Polymers: Recent Advances in Photodynamic Therapy against Cancer. | Pharmaceutics | 2023 | 37765191 | PubTator, text mining | PubMed |
| Innovative Design of Targeted Nanoparticles: Polymer-Drug Conjugates for Enhanced Cancer Therapy. | Pharmaceutics | 2023 | 37765185 | PubTator, text mining | PubMed |
| Glioma Stem Cells Are Sensitized to BCL-2 Family Inhibition by Compromising Histone Deacetylases. | Int J Mol Sci | 2023 | 37761989 | PubTator, text mining | PubMed |
| Ligand Composition and Coating Density Co-Modulate the Chondrocyte Function on Poly(glycerol-dodecanedioate). | J Funct Biomater | 2023 | 37754882 | PubTator, text mining | PubMed |
| Cellular senescence throws new insights into patient classification and pharmacological interventions for clinical management of hepatocellular carcinoma. | World J Gastrointest Oncol | 2023 | 37746655 | PubTator, text mining | PubMed |
| Emerging proteins involved in castration‑resistant prostate cancer via the AR‑dependent and AR‑independent pathways (Review). | Int J Oncol | 2023 | 37732538 | PubTator, text mining | PubMed |
| Identification of early diagnostic biomarkers for breast cancer through bioinformatics analysis. | Medicine (Baltimore) | 2023 | 37713876 | PubTator, text mining | PubMed |
| RHAMM/hyaluronan inhibit β-catenin degradation, enhance downstream signaling, and facilitate fibrosarcoma cell growth. | Mol Biol Rep | 2023 | 37710072 | PubTator, text mining | PubMed |
| An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers. | Cancer Res Commun | 2023 | 37707389 | PubTator, text mining | PubMed |
| Divergent CD4+ T-cell profiles are associated with anti-HLA alloimmunization status in platelet-transfused AML patients. | Front Immunol | 2023 | 37701444 | PubTator, text mining | PubMed |
| SPP1/osteopontin: a driver of fibrosis and inflammation in degenerative ascending aortic aneurysm? | J Mol Med (Berl) | 2023 | 37698712 | PubTator, text mining | PubMed |
| Androgen receptor and hyaluronan-mediated motility receptor as new molecular targets of baicalein: new molecular mechanisms for its anticancer properties. | Arch Pharm Res | 2023 | 37691050 | PubTator, text mining | PubMed |
| Modern Approaches in Wounds Management. | Polymers (Basel) | 2023 | 37688274 | PubTator, text mining | PubMed |
| Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer. | Br J Cancer | 2023 | 37673961 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3161/papers?page=11